$196 Million is the total value of First Light Asset Management, LLC's 62 reported holdings in Q1 2015. The portfolio turnover from Q4 2014 to Q1 2015 was 12.1% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ATRC | Buy | ATRICURE INCcs | $14,457,000 | +13.9% | 705,570 | +10.9% | 7.38% | +2.6% |
| NEO | Buy | NEOGENOMICS INCcs | $13,833,000 | +23.6% | 2,962,024 | +10.4% | 7.06% | +11.4% |
| AKRXQ | Buy | AKORN INCcs | $12,149,000 | +44.2% | 255,711 | +9.9% | 6.20% | +30.0% |
| HBIO | Buy | HARVARD BIOSCIENCE INCcs | $9,094,000 | +13.5% | 1,562,504 | +10.6% | 4.64% | +2.3% |
| RTIX | Buy | RTI BIOLOGICS INCcs | $7,720,000 | +5.0% | 1,562,664 | +10.5% | 3.94% | -5.4% |
| NXTM | Buy | NXSTAGE MEDICAL INCcs | $7,123,000 | +6.5% | 411,717 | +10.3% | 3.64% | -4.1% |
| LGND | Buy | LIGAND PHARMACEUTICALS INCcs | $7,047,000 | +61.6% | 91,384 | +11.5% | 3.60% | +45.6% |
| IG | Buy | IGI INCcs | $6,579,000 | +1.8% | 806,255 | +9.8% | 3.36% | -8.3% |
| TEAR | Buy | TEARLAB CORPcs | $5,871,000 | +132.4% | 2,950,478 | +209.5% | 3.00% | +109.5% |
| OXFD | Buy | OXFORD IMMUNOTEC GLOBAL PLCcs | $5,775,000 | +55.0% | 410,150 | +50.0% | 2.95% | +39.7% |
| ELGX | Buy | ENDOLOGIX INCcs | $4,733,000 | +23.6% | 277,264 | +10.7% | 2.42% | +11.4% |
| CLDX | Buy | CELLDEX THERAPEUTICS INC NEWcs | $4,714,000 | +68.1% | 169,145 | +10.1% | 2.41% | +51.5% |
| OMCL | Buy | OMNICELL INCcs | $4,698,000 | +17.7% | 133,858 | +11.1% | 2.40% | +6.1% |
| INSM | New | INSMED INCcs | $4,369,000 | – | 210,066 | +100.0% | 2.23% | – |
| TECH | Buy | BIO TECHNE CORPcs | $4,316,000 | +19.0% | 43,036 | +9.7% | 2.20% | +7.3% |
| QDEL | Buy | QUIDEL CORPcs | $4,254,000 | +2.8% | 157,665 | +10.2% | 2.17% | -7.4% |
| NVDQ | Buy | NOVADAQ TECHNOLOGIES INCcs | $3,966,000 | +7.0% | 244,238 | +9.6% | 2.02% | -3.6% |
| ENZ | Buy | ENZO BIOCHEM INCcs | $3,907,000 | -27.5% | 1,324,322 | +9.1% | 2.00% | -34.7% |
| ANGO | Buy | ANGIODYNAMICS INCcs | $3,839,000 | +3.8% | 215,783 | +10.9% | 1.96% | -6.5% |
| FLDM | Buy | FLUIDIGM CORP DELcs | $3,768,000 | +38.6% | 89,492 | +11.0% | 1.92% | +24.9% |
| STRM | Buy | STREAMLINE HEALTH SOLUTIONScs | $3,537,000 | -9.6% | 996,235 | +10.2% | 1.81% | -18.5% |
| LCI | Buy | LANNET INCcs | $3,370,000 | +71.8% | 49,769 | +8.7% | 1.72% | +54.8% |
| VCYT | Buy | VERACYTE INCcs | $3,203,000 | -15.8% | 440,003 | +11.7% | 1.64% | -24.1% |
| BMRN | Buy | BIOMARIN PHARMACEUTICAL INCcs | $3,066,000 | +53.8% | 24,606 | +11.5% | 1.57% | +38.6% |
| CPHD | Buy | CEPHEIDcs | $2,833,000 | +16.9% | 49,784 | +11.2% | 1.45% | +5.4% |
| STAA | Buy | STAAR SURGICAL COcs | $2,531,000 | -9.3% | 340,662 | +11.2% | 1.29% | -18.3% |
| LMAT | Buy | LEMAITRE VASCULAR INCcs | $2,448,000 | +21.6% | 292,119 | +11.0% | 1.25% | +9.6% |
| HSTM | Buy | HEALTHSTREAM INCcs | $2,311,000 | -4.9% | 91,690 | +11.2% | 1.18% | -14.3% |
| VRTX | Buy | VERTEX PHARMACEUTICALS INCcs | $2,284,000 | +9.3% | 19,365 | +10.1% | 1.17% | -1.5% |
| AMAG | New | AMAG PHARMACEUTICALS INCcs | $2,224,000 | – | 40,695 | +100.0% | 1.14% | – |
| BLUE | Buy | BLUEBIRD BIO INCcs | $2,140,000 | +45.8% | 17,718 | +10.7% | 1.09% | +31.4% |
| VSTM | New | VERASTEM INCcs | $2,115,000 | – | 207,922 | +100.0% | 1.08% | – |
| STKL | Buy | SUNOPTA INCcs | $1,566,000 | -0.6% | 147,418 | +10.9% | 0.80% | -10.4% |
| CYTK | Buy | CYTOKINETICS INC COMcs | $1,349,000 | -6.0% | 199,014 | +11.1% | 0.69% | -15.3% |
| PETX | Buy | ARATANA THERAPEUTICS INCcs | $1,028,000 | -0.7% | 64,206 | +10.6% | 0.52% | -10.6% |
| MYL | New | MYLAN N Vcs | $580,000 | – | 9,775 | +100.0% | 0.30% | – |
| BDX | Buy | BECTON DICKINSON AND COcs | $487,000 | +25.2% | 3,395 | +21.5% | 0.25% | +13.2% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2015-05-15
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ATRICURE INC | 43 | Q2 2024 | 9.7% |
| NEOGENOMICS INC | 43 | Q2 2024 | 10.6% |
| SANOFI-SYNTHELABO | 41 | Q4 2023 | 1.9% |
| JOHNSON & JOHNSON | 41 | Q4 2023 | 0.3% |
| PFIZER INC | 39 | Q2 2023 | 0.9% |
| BIOMARIN PHARMACEUTICAL INC | 37 | Q4 2023 | 1.6% |
| NOVARTIS AG-SPONSORED ADR | 34 | Q4 2023 | 0.4% |
| OMNICELL INC | 33 | Q3 2023 | 7.7% |
| QUIDEL CORP | 33 | Q4 2021 | 3.7% |
| MODEL N INC | 32 | Q1 2024 | 9.0% |
View First Light Asset Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| OptimizeRx Corp | June 10, 2024 | 1,829,074 | 10.0% |
| TELA Bio, Inc.Sold out | June 10, 2024 | 0 | 0.0% |
| Societal CDMO, Inc. | April 09, 2024 | ? | ? |
| KORU Medical Systems, Inc. | February 14, 2024 | 5,158,444 | 11.3% |
| Performant Financial Corp | February 14, 2024 | 9,696,781 | 12.6% |
| PLIANT THERAPEUTICS, INC. | February 14, 2024 | 3,634,510 | 6.1% |
| SI-BONE, Inc. | February 14, 2024 | 2,532,227 | 6.2% |
| Sonendo, Inc. | February 14, 2024 | 5,446,491 | 10.0% |
| Miromatrix Medical Inc. | December 07, 2023 | 2,592,022 | 9.4% |
| Orthofix Medical Inc.Sold out | October 30, 2023 | 0 | 0.0% |
View First Light Asset Management, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| N-PX | 2024-08-15 |
| 13F-HR | 2024-08-14 |
| SC 13G | 2024-08-09 |
| SC 13G/A | 2024-07-10 |
| SC 13G/A | 2024-06-10 |
| SC 13G/A | 2024-06-10 |
| 13F-HR | 2024-05-15 |
| SC 13D/A | 2024-04-09 |
| 4 | 2024-04-08 |
| 13F-HR | 2024-02-14 |
View First Light Asset Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.